Literature DB >> 8024214

Immune response to Moraxella catarrhalis in children with otitis media: opsonophagocytosis with antigen-coated latex beads.

H Faden1, J J Hong, N Pahade.   

Abstract

Opsonic antibody activity against Moraxella catarrhalis was determined in sera from children with otitis media. The antibody was determined with a new assay utilizing outer membrane antigen-coated latex beads. Antigen-coated beads opsonized in heat-inactivated pooled human serum phagocytosed 47.5 +/- 36.1 beads per 100 neutrophils compared to 15.6 +/- 10.2 beads per 100 neutrophils opsonized in hypogammaglobulinemic serum (p < .025). Antigen-coated beads opsonized in homologous sera from 11 children with M. catarrhalis otitis media demonstrated increased opsonic activity in convalescent sera (34.6 +/- 27.1) compared to acute sera (15.5 +/- 6.7; p < .05). These data suggest that infection with M catarrhalis is associated with the development of opsonic antibody.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8024214     DOI: 10.1177/000348949410300704

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  9 in total

1.  Adenovirus serotype 1 does not act synergistically with Moraxella (Branhamella) catarrhalis to induce otitis media in the chinchilla.

Authors:  L O Bakaletz; D M Murwin; J M Billy
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 2.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

3.  Mapping of a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis.

Authors:  C Aebi; L D Cope; J L Latimer; S E Thomas; C A Slaughter; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

4.  A protective epitope of Moraxella catarrhalis is encoded by two different genes.

Authors:  C Aebi; I Maciver; J L Latimer; L D Cope; M K Stevens; S E Thomas; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

5.  Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins.

Authors:  W G Hu; J Chen; J F Battey; X X Gu
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  Human immune response to outer membrane protein CD of Moraxella catarrhalis in adults with chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Charmaine Kirkham; Dai-Fang Liu; Sanjay Sethi
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

Review 7.  Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

Authors:  T F Murphy
Journal:  Microbiol Rev       Date:  1996-06

8.  Intranasal immunization with a colloid-formulated bacterial extract induces an acute inflammatory response in the lungs and elicits specific immune responses.

Authors:  A Rial; D Lens; L Betancor; H Benkiel; J S Silva; J A Chabalgoity
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  Mucosal immunization with the Moraxella Catarrhalis porin m35 induces enhanced bacterial clearance from the lung: a possible role for opsonophagocytosis.

Authors:  Donna M Easton; Allan W Cripps; A Ruth Foxwell; Jennelle M Kyd
Journal:  Front Immunol       Date:  2011-05-16       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.